The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Hepatic Xenetix-CT Perfusion
Official Title: Diagnostic Contribution of XENETIX® CT PERFUSION in Pre-therapeutical Assessment of Hepatocellular Carcinoma
Study ID: NCT01639703
Brief Summary: The purpose of this study is to prospectively determine the diagnostic value of Xenetix-CT perfusion for the discrimination between well-differentiated hepatocellular carcinomas (HCC) and poorly/moderately differentiated HCC, in histo-pathologically proven HCC, and with the aim to cover the entire liver.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
AKH, Vienna, , Austria
Universitätsklinikum Erlangen, Erlangen, , Germany
SMC, Seoul, , Korea, Republic of
SNUH, Seoul, , Korea, Republic of
Zurich University Hospital, Zurich, , Switzerland
Name: Hatem Alkadhi
Affiliation: Zurich University Hospital
Role: PRINCIPAL_INVESTIGATOR